85 related articles for article (PubMed ID: 9040988)
1. Synthesis and biological evaluation of novel pyrrolidine-2,5-dione inhibitors as potential anti-tumour agents.
Ahmed S; Smith JH; Nicholls PJ; Whomsley R; Cariuk P
Drug Des Discov; 1995 Apr; 12(4):275-87. PubMed ID: 9040988
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological evaluation of imidazole based compounds as cytochrome P-450 inhibitors.
Ahmed S; Smith JH; Nicholls PJ; Whomsley R; Cariuk P
Drug Des Discov; 1995 Aug; 13(1):27-41. PubMed ID: 8882899
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and biochemical evaluation of analogues of aminoglutethimide based on phenylpyrrolidine-2,5-dione.
Daly MJ; Jones GW; Nicholls PJ; Smith HJ; Rowlands MG; Bunnett MA
J Med Chem; 1986 Apr; 29(4):520-3. PubMed ID: 3754286
[TBL] [Abstract][Full Text] [Related]
4. Tetrahydronaphthalenes: influence of heterocyclic substituents on inhibition of steroid enzymes P450 arom and P450 17.
Wächter GA; Hartmann RW; Sergejew T; Grün GL; Ledergerber D
J Med Chem; 1996 Feb; 39(4):834-41. PubMed ID: 8632407
[TBL] [Abstract][Full Text] [Related]
5. Analogues of aminoglutethimide based on 1-phenyl-3-azabicyclo[3.1.0]hexane-2,4-dione: selective inhibition of aromatase activity.
Rowlands MG; Bunnett MA; Foster AB; Jarman M; Stanek J; Schweizer E
J Med Chem; 1988 May; 31(5):971-6. PubMed ID: 3361583
[TBL] [Abstract][Full Text] [Related]
6. Some 1-, and 3-substituted 3-(4'-aminophenyl)pyrrolidine-2,5-diones as selective inhibitors of aromatase.
Whomsley R; Smith HJ; Nicholls PJ; Nazareth W; Ahmadi M
J Enzyme Inhib; 1992; 6(4):317-30. PubMed ID: 1284968
[TBL] [Abstract][Full Text] [Related]
7. Selective inhibition of cholesterol side-chain cleavage by potential pro-drug forms of aminoglutethimide.
Jarman M; Barrie SE; Leung CS; Rowlands MG
Anticancer Drug Des; 1988 Dec; 3(3):185-90. PubMed ID: 3264700
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, biochemical evaluation and rationalisation of the inhibitory activity of a range of phenyl alkyl imidazole-based compounds as potent inhibitors of the enzyme complex 17alpha-hydroxylase/17,20-lyase (P450(17alpha)).
Owen CP; Shahid I; Olusanjo MS; Patel CH; Dhanani S; Ahmed S
J Steroid Biochem Mol Biol; 2008 Jul; 111(1-2):117-27. PubMed ID: 18620055
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and aromatase inhibition of 3-cycloalkyl-substituted 3-(4-aminophenyl)piperidine-2,6-diones.
Hartmann RW; Batzl C; Pongratz TM; Mannschreck A
J Med Chem; 1992 Jun; 35(12):2210-4. PubMed ID: 1613747
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of enzymes of estrogen and androgen biosynthesis by esters of 4-pyridylacetic acid.
McCague R; Rowlands MG; Barrie SE; Houghton J
J Med Chem; 1990 Nov; 33(11):3050-5. PubMed ID: 2231604
[TBL] [Abstract][Full Text] [Related]
11. 1-Alkyl analogues of aminoglutethimide. Comparative inhibition of cholesterol side chain cleavage and aromatase and metabolism of the 1-propyl derivative, a highly selective inhibitor of aromatase.
Seago A; Baker MH; Houghton J; Jarman M; Leung CS; Rowlands MG
Biochem Pharmacol; 1988 Jun; 37(11):2167-72. PubMed ID: 3377817
[TBL] [Abstract][Full Text] [Related]
12. Pharmacology of aminoglutethimide: structure/activity relationships and receptor interactions.
Nicholls PJ; Daly MJ; Smith HJ
Breast Cancer Res Treat; 1986; 7 Suppl():S55-67. PubMed ID: 3755630
[TBL] [Abstract][Full Text] [Related]
13. R 76713 and enantiomers: selective, nonsteroidal inhibitors of the cytochrome P450-dependent oestrogen synthesis.
Vanden Bossche H; Willemsens G; Roels I; Bellens D; Moereels H; Coene MC; Le Jeune L; Lauwers W; Janssen PA
Biochem Pharmacol; 1990 Oct; 40(8):1707-18. PubMed ID: 2242008
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the racemate and the enantiomers of a new highly active and selective aromatase inhibitor of the aminoglutethimide type.
Hartmann RW; Grün G; Bartz U; Palzer M
J Steroid Biochem Mol Biol; 1992 Dec; 43(7):641-8. PubMed ID: 1472456
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biochemical evaluation of a range of potent benzyl imidazole-based compounds as potential inhibitors of the enzyme complex 17alpha-hydroxylase/17,20-lyase (P450(17alpha)).
Owen CP; Dhanani S; Patel CH; Shahid I; Ahmed S
Bioorg Med Chem Lett; 2006 Aug; 16(15):4011-5. PubMed ID: 16750362
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of aromatase (P450Arom) by some 1-(benzofuran-2-ylmethyl)imidazoles.
Owen CP; Nicholls PJ; Smith HJ; Whomsley R
J Pharm Pharmacol; 1999 Apr; 51(4):427-33. PubMed ID: 10385215
[TBL] [Abstract][Full Text] [Related]
17. Esters of 3-pyridylacetic acid that combine potent inhibition of 17 alpha-hydroxylase/C17,20-lyase (cytochrome P45017 alpha) with resistance to esterase hydrolysis.
Rowlands MG; Barrie SE; Chan F; Houghton J; Jarman M; McCague R; Potter GA
J Med Chem; 1995 Oct; 38(21):4191-7. PubMed ID: 7473546
[TBL] [Abstract][Full Text] [Related]
18. Analogues of 3-ethyl-3-(4-pyridyl)piperidine-2,6-dione as selective inhibitors of aromatase: derivatives with variable 1-alkyl and 3-alkyl substituents.
Leung CS; Rowlands MG; Jarman M; Foster AB; Griggs LJ; Wilman DE
J Med Chem; 1987 Sep; 30(9):1550-4. PubMed ID: 3625703
[TBL] [Abstract][Full Text] [Related]
19. Selective aromatase inhibition by pyridoglutethimide, an analogue of aminoglutethimide.
Kitawaki J; Yamamoto T; Urabe M; Tamura T; Inoue S; Honjo H; Okada H
Acta Endocrinol (Copenh); 1990 May; 122(5):592-8. PubMed ID: 2353556
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological evaluation of 3-(prop-2-enyl)- and 3-(prop-2-ynyl)pyrrolidine-2,5-dione derivatives as potential aromatase inhibitors.
Barrell KJ; Woo WL; Ahmadi M; Smith HJ; Nicholls PJ
J Pharm Pharmacol; 1996 Feb; 48(2):154-9. PubMed ID: 8935164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
